Bottom line
ERHSX vs PHSYX: the short answer
ERHSX (Eaton Vance Worldwide Health Sciences Fund) and PHSYX (Putnam Global Health Care Fund) are both mutual funds.
But PHSYX is far broader, holding 115 positions to 42 for ERHSX, so beyond the top names it adds exposure ERHSX doesn't have.
PHSYX is cheaper at 0.79% vs 1.43% — a difference of $64 a year per $10,000 invested.
Over five years, PHSYX returned +8.1% a year vs +6.2% for ERHSX.
Updated Nov 19, 2026
ERHSX vs PHSYX side by side
| ERHSX | PHSYX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Morgan Stanley | Franklin Templeton |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.43% | 0.79% |
| Annual cost per $10k | $143 | $79 |
| 10-yr cost on $10k (prospectus) | $1,744 | $978 |
| Max front load | 0% | 0% |
| 12b-1 fee | 0.5% | 0% |
| 1-yr return | +3.2% | +1.5% |
| 5-yr return (annualized) | +6.2% | +8.1% |
| 10-yr return (annualized) | +6.7% | +7.8% |
| Best quarter | — | — |
| Worst quarter | — | — |
| Net assets (fund) | $757.9M | $1.5B |
| Number of holdings | 42 | 115 |
| Portfolio turnover | 3% | 67% |
| Returns as of | Dec 31, 2024 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
16 of ERHSX's top 25 holdings also appear in PHSYX's top 25.
| Holding | ERHSX | PHSYX |
|---|---|---|
| Eli Lilly & Co | 12.47% | 13.15% |
| AbbVie Inc | 6.46% | 6.05% |
| Johnson & Johnson | 6.45% | 8.46% |
| AstraZeneca PLC | 6.24% | 4.67% |
| UnitedHealth Group Inc | 5.49% | 6.93% |
| Roche Holding AG | 5.44% | 2.79% |
| Merck & Co Inc | 5.08% | 4.88% |
| Bristol-Myers Squibb Co | 4.25% | 1.75% |
| Vertex Pharmaceuticals Inc | 3.38% | 1.97% |
| Gilead Sciences Inc | 3.34% | 2.63% |
| Sanofi SA | 2.95% | 3.23% |
| Thermo Fisher Scientific Inc | 2.79% | 4.50% |
| Intuitive Surgical Inc | 2.72% | 4.04% |
| Boston Scientific Corp | 2.18% | 1.80% |
| Novo Nordisk A/S | 1.71% | 1.90% |
Source: SEC Form N-PORT
ERHSX top 10
- Eli Lilly & Co — 12.47%
- AbbVie Inc — 6.46%
- Johnson & Johnson — 6.45%
- AstraZeneca PLC — 6.24%
- UnitedHealth Group Inc — 5.49%
- Roche Holding AG — 5.44%
- Merck & Co Inc — 5.08%
- Bristol-Myers Squibb Co — 4.25%
- Vertex Pharmaceuticals Inc — 3.38%
- Gilead Sciences Inc — 3.34%
PHSYX top 10
- Eli Lilly & Co. — 13.15%
- Johnson & Johnson — 8.46%
- UnitedHealth Group, Inc. — 6.93%
- AbbVie, Inc. — 6.05%
- Novartis AG — 5.13%
- Merck & Co., Inc. — 4.88%
- AstraZeneca plc — 4.67%
- Thermo Fisher Scientific, Inc. — 4.50%
- Intuitive Surgical, Inc. — 4.04%
- Sanofi SA — 3.23%
FAQ
What is the difference between ERHSX and PHSYX?
Which is cheaper, ERHSX or PHSYX?
Should I own both ERHSX and PHSYX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.